Can Risperdal (risperidone) cause increased sexual dysfunction?

Yes, Risperdal (risperidone) causes significant sexual dysfunction and is among the highest-risk antipsychotics for this adverse effect.

Risperdal directly causes sexual dysfunction through hyperprolactinemia, with the FDA label explicitly warning about this effect across all age groups 1. The mechanism is clear: risperidone's potent D2 receptor blockade leads to prolactin elevation, which disrupts the hypothalamic-pituitary-gonadal axis and directly impairs sexual function.

Magnitude of the Problem

The evidence consistently demonstrates high rates of sexual dysfunction with risperidone:

• Clinical trials show 82-87% of adolescents on risperidone develop elevated prolactin levels compared to only 3-7% on placebo 1
• In adult populations, 43-86% experience sexual dysfunction, with rates varying by assessment method but consistently higher than other atypical antipsychotics 2, 3, 4, 5
• Female patients show particularly high rates: 93% in one comparative study versus 83% with olanzapine 2

Specific Sexual Dysfunctions Caused

Risperidone impairs multiple domains of sexual function:

• Decreased libido (most common across all studies)
• Erectile dysfunction in males
• Anejaculation and orgasmic dysfunction 6
• Reduced arousal and pleasure 2
• Galactorrhea (0.8% in pediatric trials) 1
• Gynecomastia (2.3% in pediatric trials) 1
• Priapism (rare but serious emergency) 7

Clinical Context and Comparison

Risperidone ranks among the highest-risk antipsychotics for sexual dysfunction, second only to ziprasidone in some analyses 8. When directly compared:

• Risperidone: 43-93% sexual dysfunction rate 2, 3, 4, 5
• Olanzapine: 16-48% 3, 5
• Clozapine: 31% 3
• Aripiprazole: 14.3% 4

The FDA label confirms that prolactin elevation is dose-dependent and generally greater in females than males 1.

Critical Clinical Pitfall

The vast majority of patients (92.7%) do not spontaneously report sexual dysfunction 4. You must directly ask about sexual side effects using specific questions about libido, arousal, orgasm, and satisfaction—otherwise, this medication-limiting adverse effect goes undetected while silently eroding adherence.

Management Algorithm

When sexual dysfunction occurs on risperidone:

1. Confirm the dysfunction is treatment-emergent (not pre-existing from the underlying psychiatric illness)
2. Check serum prolactin level to document hyperprolactinemia
3. Switch to a prolactin-sparing antipsychotic:
   • Aripiprazole (14.3% dysfunction rate, may actually lower prolactin) 4
   • Lurasidone (no sexual dysfunction reported in clinical trials as of current evidence) 6
   • Quetiapine or clozapine (lower rates but other tolerability concerns)

Do not attempt dose reduction as the primary strategy—the prolactin elevation is inherent to risperidone's mechanism and occurs even at lower doses 1.

Long-term Concerns

The FDA explicitly states that "the long-term effects of risperidone on growth and sexual maturation have not been fully evaluated" 1. This is particularly concerning in pediatric and adolescent populations where chronic hyperprolactinemia may affect bone density, fertility, and pubertal development.

Guideline Context

While guidelines note that antipsychotic polypharmacy increases sexual dysfunction risk 9, the primary issue with risperidone is its inherent prolactin-elevating properties as monotherapy. The 2021 guideline confirms that combining aripiprazole with high-prolactin antipsychotics can reduce hyperprolactinemia and sexual dysfunction 9, but switching entirely away from risperidone is more definitive.

Bottom line: Risperidone causes sexual dysfunction in the majority of patients through hyperprolactinemia. Directly screen for it at every visit, and strongly consider switching to aripiprazole or lurasidone when it occurs, as this adverse effect is a leading cause of medication non-adherence and treatment failure.